Skip to main content
Top
Published in: Osteoporosis International 9/2016

01-09-2016 | Editorial

The use of finite element analysis to estimate the changing strength of bone following treatment for osteoporosis

Author: D. B. Burr

Published in: Osteoporosis International | Issue 9/2016

Login to get access

Excerpt

Finite element analysis (FEA) is a computational technique widely used to estimate the behavior of structures under loading. It is particularly valuable to investigate those conditions which cannot be studied directly by experimentation, and therefore, provides valuable information that cannot be obtained in more direct ways. It has been beneficial in helping to create and optimize non-biological structures for instance, how to engineer an airplane wing to prevent failure from excessive fatigue loading but can also help us to understand how a structure might behave mechanically under various conditions that cannot be reproduced experimentally. Briefly, the technique uses a series of small elements that can be a variety of shapes, and that are connected at nodal points, to computer-generate a morphological structure, such as a hip joint. The elements can be assigned properties that are indicative of the tissue properties that small areas of the biological structure have, either relying on measurements that have been made of the properties of the material, or in those cases in which the properties have not been measured, estimating them based on what we do know. For most models, properties for elastic modulus (tissue stiffness) are assigned to the entire structure, which can be a poor representation of bone tissue properties given one’s heterogeneity, rather than to individual elements, A virtual load can be applied to this structure, and the displacement (or deformation) of the structure under that loading condition can be estimated. A second method, known as the flexibility method, is based on known displacements. Knowing the load and the displacement, it is possible to calculate the stresses and strains within the structure, which can provide valuable information to estimate how the structure will “perform” mechanically. Stresses and strains are “derived” parameters that require calculation from the estimated displacements, so are less accurate (or more variable) than the estimated displacements [1]. Nevertheless, the FEA can provide an estimate of the stresses and strains within a structure that cannot be determined in other ways because they cannot be directly measured. If it were possible to do an experiment in which the effect could be directly measured, then FEA is not particularly helpful (just do the experiment). But it is a valuable tool for making predictions about how a structure will behave mechanically and when it might fail in situations in which it is impossible to make such measurements. …
Literature
1.
go back to reference Jacobs CR, Kelly DJ (2011) Cell mechanics: the role of simulation. In: Fernandes PR, Bartolo PJ (eds) Advances on modeling in tissue engineering. Computational methods in applied sciences, vol. 20. Springer, London Jacobs CR, Kelly DJ (2011) Cell mechanics: the role of simulation. In: Fernandes PR, Bartolo PJ (eds) Advances on modeling in tissue engineering. Computational methods in applied sciences, vol. 20. Springer, London
2.
go back to reference Ward J, Wood C, Rouch K, Pienkowski D, Malluche HH (2016) Stiffness and strength of bone in osteoporotic patients treated with varying durations of oral bisphosphonates. Osteoporos Int. doi:10.1007/s00198-016-3661-0 Ward J, Wood C, Rouch K, Pienkowski D, Malluche HH (2016) Stiffness and strength of bone in osteoporotic patients treated with varying durations of oral bisphosphonates. Osteoporos Int. doi:10.​1007/​s00198-016-3661-0
3.
go back to reference Burr DB, Liu Z, Allen MR (2015) Duration-dependent effects of clinically relevant oral alendronate doses on cortical bone toughness in beagle dogs. Bone 71:58–62CrossRefPubMed Burr DB, Liu Z, Allen MR (2015) Duration-dependent effects of clinically relevant oral alendronate doses on cortical bone toughness in beagle dogs. Bone 71:58–62CrossRefPubMed
4.
go back to reference Dell RM, Adams AL, Greene DF, Funahashi TT, Silverman SL, Eisemon EO, Zhou H, Burchette RJ, Ott SM (2012) Incidence of atypical nontraumatic diaphyseal fractures of the femur. J Bone Miner Res 27:2544–2550CrossRefPubMed Dell RM, Adams AL, Greene DF, Funahashi TT, Silverman SL, Eisemon EO, Zhou H, Burchette RJ, Ott SM (2012) Incidence of atypical nontraumatic diaphyseal fractures of the femur. J Bone Miner Res 27:2544–2550CrossRefPubMed
6.
go back to reference Shane E, Burr DB, Abrahamsen B, et al. (2014) Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for bone and mineral research. J Bone Miner Res 29:1–23CrossRefPubMed Shane E, Burr DB, Abrahamsen B, et al. (2014) Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for bone and mineral research. J Bone Miner Res 29:1–23CrossRefPubMed
7.
go back to reference Shane E, Burr D, Ebeling PR, et al. (2010) Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for bone and mineral research. J Bone Miner Res 25:1–28CrossRef Shane E, Burr D, Ebeling PR, et al. (2010) Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for bone and mineral research. J Bone Miner Res 25:1–28CrossRef
8.
go back to reference Ettinger B, Burr DB, Ritchie RO (2013) Proposed pathogenesis for atypical femoral fractures: lessons from materials research. Bone 55:495–500CrossRefPubMed Ettinger B, Burr DB, Ritchie RO (2013) Proposed pathogenesis for atypical femoral fractures: lessons from materials research. Bone 55:495–500CrossRefPubMed
9.
go back to reference Idris AI, Rojas J, Greig IR, Van’t Hof RJ, Ralson SH (2008) Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro. Calcif Tissue Int 82:191–201CrossRefPubMed Idris AI, Rojas J, Greig IR, Van’t Hof RJ, Ralson SH (2008) Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro. Calcif Tissue Int 82:191–201CrossRefPubMed
10.
go back to reference Orriss IR, Key KL, Colston KW, Arnett TR (2009) Inhibition of osteoblast function in vitro by aminobisphosphonates. J Cell Biochem 106:109–118CrossRefPubMed Orriss IR, Key KL, Colston KW, Arnett TR (2009) Inhibition of osteoblast function in vitro by aminobisphosphonates. J Cell Biochem 106:109–118CrossRefPubMed
11.
go back to reference Koch FP, Yekta SS, Merkel C, Ziebart T, Smeets R (2010) The impact of bisphosphonates on the osteoblast proliferation and collagen gene expression in vitro. Head Face Med 6:12CrossRefPubMedPubMedCentral Koch FP, Yekta SS, Merkel C, Ziebart T, Smeets R (2010) The impact of bisphosphonates on the osteoblast proliferation and collagen gene expression in vitro. Head Face Med 6:12CrossRefPubMedPubMedCentral
12.
go back to reference Iwata K, Li J, Follet H, Phipps RJ, Burr DB (2006) Bisphosphonates suppress periosteal osteoblast activity independently of resorption in rat femur and tibia. Bone 39:1053–1058CrossRefPubMed Iwata K, Li J, Follet H, Phipps RJ, Burr DB (2006) Bisphosphonates suppress periosteal osteoblast activity independently of resorption in rat femur and tibia. Bone 39:1053–1058CrossRefPubMed
Metadata
Title
The use of finite element analysis to estimate the changing strength of bone following treatment for osteoporosis
Author
D. B. Burr
Publication date
01-09-2016
Publisher
Springer London
Published in
Osteoporosis International / Issue 9/2016
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-016-3707-3

Other articles of this Issue 9/2016

Osteoporosis International 9/2016 Go to the issue